Results for tag: "Caspases Activator"

The Caspases Activator market is a subset of the Immune Disorders Drugs market. Caspases Activators are drugs that target caspases, a family of enzymes that play a role in the regulation of the immune system. These drugs are used to treat a variety of immune-related disorders, including autoimmune diseases, inflammatory diseases, and allergies. Caspases Activators are designed to reduce inflammation and improve the body's ability to fight off infection. Caspases Activators are typically administered orally or intravenously, and can be used in combination with other drugs to treat more severe cases of immune-related disorders. They are also used in combination with other therapies, such as physical therapy, to improve the patient's overall health. Some companies in the Caspases Activator market include AbbVie, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more